Publications

Publications From: Ralph D'Agostino, PhD

Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study.Circulation. 2009 Jul 21;120(3):212-20.

Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation. 2009 Apr 7;119(13):1728-35.

Prevalence, clinical correlates, and prognosis of discrete upper septal thickening on echocardiography: the Framingham Heart Study. Echocardiography. 2009 Mar;26(3):247-53.

Relation of Corneal Arcus to Cardiovascular Disease (from the Framingham Heart Study Data Set). Am J Cardiol. 2009 Jan 1;103(1):64-6.

Vitamin E supplement use and the incidence of cardiovascular disease and all-cause mortality in the Framingham Heart Study: Does the underlying health status play a role? Atherosclerosis. 2008 Dec 24.

Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J. 2008 Nov;156(5):855-63, 863.e2.

Interindividual variation in serum sodium and longitudinal blood pressure tracking in the Framingham Heart Study. J Hypertens. 2008 Nov;26(11):2121-5.

Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study. Stroke. 2008 Nov;39(11):2929-35.

Von Willebrand Factor, Type 2 Diabetes Mellitus, and Risk of Cardiovascular Disease. The Framingham Offspring Study. Circulation. 2008 Nov 24.

Long-term trends in the incidence of heart failure after myocardial infarction. Circulation. 2008 Nov 11;118(20):2019-21.

Effect of Aging on A1C Levels in Persons without Diabetes: Evidence from the Framingham Offspring Study and NHANES 2001-2004. Diabetes Care. 2008 Jul 15.

Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008 Jul 9;300(2):197-208.

Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study. Arch Neurol. 2008 May;65(5):

Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007 Mar 8;356(10):1020-9.

Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J. 2006 Jul;152(1):59-66.